Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas

Fig. 3

Prevalence of individuals presenting antibodies that recognizes GLURP, MSP-3, and Pfs48/45. The data refer to the prevalence of individuals with IgG, IgM, IgA and/or IgE detectable antibodies in each group studied. *P < 0.01, CZS MSP-3 versus ML MSP-3; P < 0.0001, CZS MSP-3 versus GJ MSP-3. Prevalence of responders were compared by Chi-squared tests

Back to article page